We re-checked sixteen compounded prices at source. Fifteen were wrong
Every correction moved the price upward, which means published cheapest figures are systematically low.
Every correction moved the price upward, which means published cheapest figures are systematically low.
All-in monthly cost at 10 mg
Sixteen programme prices were verified against the provider's own published material. Fifteen needed correcting, and every correction moved the number up.
The mechanisms are structural: promotional first months, prepaid bundle rates, medication-only figures excluding mandatory memberships, and twice a semaglutide price published in a tirzepatide column.
Every one of those distortions pushes the same direction, which is why the cheapest options in any round-up are the ones most likely to be wrong.
What this changes for what you pay
Most developments in this category move one of three things: the price of the branded product, which programmes are operating, or what may lawfully be compounded. Very few change the prescription requirement, the pharmacy licensing framework or the clinical review behind a prescription.
The cheapest verified compounded route we track currently sits at $215 a month all-in at a 10 mg maintenance dose, about $2,580 for a first year. Where a development moves that figure, our tables move with it on the next build.
How to verify this yourself
Regulatory claims should be checked against the agency rather than against coverage of the agency. FDA publishes warning letters searchable by company name, a shortage database, and its compounding pages. Trial claims should be checked against the registry entry rather than a press release.
Every source behind this item is linked below, and where a story is still moving we say so rather than implying it is settled.
Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.
Compare every programme on one screen
The matrix carries all-in price at every dose, fee structure, commitment terms, pharmacy disclosure and verification status for every programme we track.